Shopping Cart
- Remove All
- Your shopping cart is currently empty
ZINC00784494, a specific Lipocalin-2 (LCN2) inhibitor, impedes cell proliferation and viability while diminishing AKT phosphorylation in SUM149 cells, showing promise for research on inflammatory breast cancer (IBC) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | ZINC00784494, a specific Lipocalin-2 (LCN2) inhibitor, impedes cell proliferation and viability while diminishing AKT phosphorylation in SUM149 cells, showing promise for research on inflammatory breast cancer (IBC) [1]. |
In vitro | ZINC00784494, at concentrations ranging from 0.01 to 100 µM over 72 hours, diminishes both cell proliferation and viability in SUM149 cells [1]. Additionally, at 1 and 10 µM, ZINC00784494 decreases phosphorylated Akt (p-Akt) levels in SUM149 cells within 15 minutes to 1 hour of treatment [1]. |
Molecular Weight | 362.4 |
Formula | C20H14N2O3S |
Cas No. | 317328-17-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.